<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>YAC Cannabinoid Compounds for ADHD</title>
    <style>
        :root {
            --primary: #2d5016;
            --secondary: #4a7c23;
            --accent: #7cb342;
            --bg: #fafafa;
            --text: #333;
            --card-bg: #fff;
        }
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, sans-serif;
            line-height: 1.6;
            color: var(--text);
            background: var(--bg);
        }
        header {
            background: linear-gradient(135deg, var(--primary), var(--secondary));
            color: white;
            padding: 3rem 2rem;
            text-align: center;
        }
        header h1 {
            font-size: 2.5rem;
            margin-bottom: 0.5rem;
        }
        header p {
            font-size: 1.1rem;
            opacity: 0.9;
            max-width: 800px;
            margin: 0 auto;
        }
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 2rem;
        }
        .section {
            margin-bottom: 3rem;
        }
        .section h2 {
            color: var(--primary);
            border-bottom: 2px solid var(--accent);
            padding-bottom: 0.5rem;
            margin-bottom: 1.5rem;
        }
        .strategy-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 1.5rem;
        }
        .strategy-card {
            background: var(--card-bg);
            border-radius: 8px;
            padding: 1.5rem;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
            border-left: 4px solid var(--accent);
        }
        .strategy-card h3 {
            color: var(--secondary);
            margin-bottom: 0.5rem;
        }
        .compound-table {
            width: 100%;
            border-collapse: collapse;
            background: var(--card-bg);
            border-radius: 8px;
            overflow: hidden;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
        }
        .compound-table th,
        .compound-table td {
            padding: 1rem;
            text-align: left;
            border-bottom: 1px solid #eee;
        }
        .compound-table th {
            background: var(--primary);
            color: white;
        }
        .compound-table tr:hover {
            background: #f5f5f5;
        }
        .badge {
            display: inline-block;
            padding: 0.25rem 0.75rem;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }
        .badge-a { background: #e3f2fd; color: #1565c0; }
        .badge-b { background: #f3e5f5; color: #7b1fa2; }
        .badge-c { background: #fff3e0; color: #ef6c00; }
        .code-block {
            background: #263238;
            color: #aed581;
            padding: 1.5rem;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', monospace;
            font-size: 0.9rem;
        }
        .btn {
            display: inline-block;
            padding: 0.75rem 1.5rem;
            background: var(--secondary);
            color: white;
            text-decoration: none;
            border-radius: 4px;
            margin-right: 1rem;
            margin-top: 1rem;
            transition: background 0.2s;
        }
        .btn:hover {
            background: var(--primary);
        }
        footer {
            background: var(--primary);
            color: white;
            text-align: center;
            padding: 2rem;
            margin-top: 3rem;
        }
        footer a {
            color: var(--accent);
        }
    </style>
</head>
<body>
    <header>
        <h1>YAC Cannabinoid Compound Library</h1>
        <p>Rational Design of Pathway-Selective Cannabinoid Compounds for ADHD: Dissociating Therapeutic Efficacy from Orexigenic Effects</p>
    </header>

    <div class="container">
        <section class="section">
            <h2>Overview</h2>
            <p>This research presents a comprehensive rational drug design framework for creating THC analogs that preserve ADHD-relevant prefrontal cortex modulation while eliminating appetite stimulation through three mechanistically distinct strategies.</p>

            <a href="https://github.com/mlong/yac-cannabinoid-adhd" class="btn">View on GitHub</a>
            <a href="paper/pathway-selective-cannabinoids-adhd.pdf" class="btn">Read Paper (PDF)</a>
        </section>

        <section class="section">
            <h2>Three Strategies</h2>
            <div class="strategy-grid">
                <div class="strategy-card">
                    <h3>Strategy A: Biased Signaling</h3>
                    <p>Gi-selective partial agonists and allosteric-orthosteric hybrids that preferentially activate therapeutic pathways through defined structural modifications.</p>
                    <p><strong>Compounds:</strong> YAC-101, YAC-102</p>
                </div>
                <div class="strategy-card">
                    <h3>Strategy B: Prodrug Activation</h3>
                    <p>CYP2D6- and esterase-activated prodrugs achieving cortex-selective activation while maintaining blood-brain barrier penetration.</p>
                    <p><strong>Compounds:</strong> YAC-201, YAC-202</p>
                </div>
                <div class="strategy-card">
                    <h3>Strategy C: Multi-Target Ligands</h3>
                    <p>Hybrid molecules engaging CB1 while antagonizing appetite-related receptors (GHSR1a, NPY Y1) or agonizing anorexigenic receptors (MC4R).</p>
                    <p><strong>Compounds:</strong> YAC-301, YAC-302</p>
                </div>
            </div>
        </section>

        <section class="section">
            <h2>Compound Library</h2>
            <table class="compound-table">
                <thead>
                    <tr>
                        <th>ID</th>
                        <th>Strategy</th>
                        <th>MW (g/mol)</th>
                        <th>logP</th>
                        <th>Key Feature</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>YAC-101</strong></td>
                        <td><span class="badge badge-a">Strategy A</span></td>
                        <td>434.5</td>
                        <td>5.8</td>
                        <td>Gi-biased partial agonist</td>
                    </tr>
                    <tr>
                        <td><strong>YAC-102</strong></td>
                        <td><span class="badge badge-a">Strategy A</span></td>
                        <td>586.7</td>
                        <td>5.2</td>
                        <td>Allosteric-orthosteric hybrid</td>
                    </tr>
                    <tr>
                        <td><strong>YAC-201</strong></td>
                        <td><span class="badge badge-b">Strategy B</span></td>
                        <td>448.6</td>
                        <td>6.2</td>
                        <td>CYP2D6 prodrug</td>
                    </tr>
                    <tr>
                        <td><strong>YAC-202</strong></td>
                        <td><span class="badge badge-b">Strategy B</span></td>
                        <td>400.6</td>
                        <td>6.5</td>
                        <td>Esterase prodrug</td>
                    </tr>
                    <tr>
                        <td><strong>YAC-301</strong></td>
                        <td><span class="badge badge-c">Strategy C</span></td>
                        <td>~1150</td>
                        <td>~3.5</td>
                        <td>CB1/GHSR1a dual ligand</td>
                    </tr>
                    <tr>
                        <td><strong>YAC-302</strong></td>
                        <td><span class="badge badge-c">Strategy C</span></td>
                        <td>~1050</td>
                        <td>~2.8</td>
                        <td>CB1/MC4R dual agonist</td>
                    </tr>
                </tbody>
            </table>
        </section>

        <section class="section">
            <h2>Quick Start</h2>
            <div class="code-block">
<pre>
# Clone and install
git clone https://github.com/mlong/yac-cannabinoid-adhd.git
cd yac-cannabinoid-adhd
pip install -r requirements.txt

# Analyze compounds
python src/compounds.py

# Generate molecular visualizations
python src/visualize.py
</pre>
            </div>
        </section>

        <section class="section">
            <h2>Python API</h2>
            <div class="code-block">
<pre>
from src.compounds import YACCompoundLibrary, MolecularAnalyzer

library = YACCompoundLibrary()
compound = library.get_compound("YAC-201")

analyzer = MolecularAnalyzer()
props = analyzer.analyze_compound(compound.smiles)
print(f"TPSA: {props['tpsa']} A^2")
</pre>
            </div>
        </section>
    </div>

    <footer>
        <p>&copy; 2024 Matthew Long / YonedaAI Research Collective</p>
        <p>
            <a href="https://github.com/mlong/yac-cannabinoid-adhd">GitHub</a> |
            <a href="paper/pathway-selective-cannabinoids-adhd.pdf">Research Paper</a>
        </p>
    </footer>
</body>
</html>
